@misc{indiciae98cfb54b5544,
  title = {Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study validate BCL-2 as a target across heterogeneous CRPC subtypes},
  author = {Jamroze, A. and Liu, X. and Hou, S. and Li, W. and Yu, H. and Tracz, A. and Li, Q. and Nastiuk, K. L. and Chen, X. and Huang, J. and Lin, K. and Lu, Y. and Puzanov, I. and Kirk, J. S. and Chatta, G. and Tang, D. G.},
  year = {2025},
  doi = {10.1101/2025.07.08.663739},
  url = {https://www.biorxiv.org/content/10.1101/2025.07.08.663739v1},
  note = {Source identifier: 10.1101/2025.07.08.663739}
}